- Home
- BIOX vs IMA Comparison
BIOX vs IMA Comparison
Compare BIOX & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- IMA
- Stock Information
- Founded
- BIOX 2001
- IMA 2019
- Country
- BIOX Argentina
- IMA United States
- Employees
- BIOX N/A
- IMA N/A
- Industry
- BIOX Agricultural Chemicals
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BIOX Industrials
- IMA Health Care
- Exchange
- BIOX Nasdaq
- IMA Nasdaq
- Market Cap
- BIOX 85.0M
- IMA 92.2M
- IPO Year
- BIOX N/A
- IMA N/A
- Fundamental
- Price
- BIOX $1.87
- IMA $8.11
- Analyst Decision
- BIOX Buy
- IMA Buy
- Analyst Count
- BIOX 3
- IMA 1
- Target Price
- BIOX $4.50
- IMA $30.00
- AVG Volume (30 Days)
- BIOX 1.4M
- IMA 91.8K
- Earning Date
- BIOX 11-10-2025
- IMA 11-15-2025
- Dividend Yield
- BIOX N/A
- IMA N/A
- EPS Growth
- BIOX N/A
- IMA N/A
- EPS
- BIOX N/A
- IMA N/A
- Revenue
- BIOX $333,300,000.00
- IMA $4,300,000.00
- Revenue This Year
- BIOX $6.77
- IMA N/A
- Revenue Next Year
- BIOX $21.39
- IMA N/A
- P/E Ratio
- BIOX N/A
- IMA N/A
- Revenue Growth
- BIOX N/A
- IMA N/A
- 52 Week Low
- BIOX $1.20
- IMA $7.24
- 52 Week High
- BIOX $7.44
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- BIOX 53.89
- IMA N/A
- Support Level
- BIOX $1.58
- IMA N/A
- Resistance Level
- BIOX $2.14
- IMA N/A
- Average True Range (ATR)
- BIOX 0.25
- IMA 0.00
- MACD
- BIOX 0.09
- IMA 0.00
- Stochastic Oscillator
- BIOX 71.99
- IMA 0.00
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.